Patients who need repeated MRI scans with contrast dye could soon receive a fraction of the gadolinium they currently get.

Results of the Phase I clinical trial, presented at the bi-annual Contrast Media Research symposium in Oslo, Norway, conclude that this novel macrocyclic manganese-based contrast agent was well ...

Scientists at the University of Birmingham have developed a new class of MRI contrast agents, improving their stability to create a significant advancement in medical imaging technology. Metallo ...

You can keep your best guesses. Engineers at Rice University's George R. Brown School of Engineering are starting to understand exactly what goes on when doctors pump contrast agents into your body ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

The launch of Pixxoscan expands GE HealthCare’s portfolio of Magnetic Resonance Imaging (MRI) contrast agents, now offering two leading macrocyclic molecules to customers - Clariscan (gadoteric acid) ...

A new magnetic resonance imaging (MRI) contrast agent being tested by researchers at Case Western Reserve University not only pinpoints breast cancers at early stages but differentiates between ...

Unlike conventional techniques that require puncturing a lymph node or inserting a catheter (B, C), the lymphatic system can ...

Simulations reveal details about the magnetic interactions between gadolinium contrast agents used in MRI scans and their environment. You can keep your best guesses. Engineers at Rice University's ...

HOUSTON – (Nov. 17, 2022) – You can keep your best guesses. Engineers at Rice University’s George R. Brown School of Engineering are starting to understand exactly what goes on when doctors pump ...